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Abstract: Background Severe prekallikrein deficiency (PK deficiency) is an autosomal‐recessive condi-
tion thought to be very rare. Recently we reported that the previously unnoticed variant c.451dupT,
p.Ser151Phefs*34 in KLKB1, which is listed in databases aggregating genome data, causes PK deficiency
and is common in Africans according to gnomAD (allele frequency 1.43%). Patients/Methods The most
common African (c.451dupT) and European (c.1643G>A, p.Cys548Tyr) PK deficiency causing KLKB1
variants were analyzed in two population‐based collectives of 300 Nigerian and 300 German subjects.
Genome databases were evaluated for variant frequencies and ethnicity of the subjects. The geographic
origin of PK‐deficient cases due to 451dupT was assessed. Results Two of five patients with PK defi-
ciency caused by homozygous 451dupT were African, one African American, one from Oman, and one
of unknown origin. The frequency of 451dupT was 1.17% in the Nigerian collective (7/600 alleles); none
had Cys548Tyr. Subjects with 451dupT were found among different Nigerian ethnicities. Both variants
were absent in the European collective. Database research was compatible with these findings, even
though mainly data of African Americans (451dupT: 1.12%‐1.78%) was accessible. A relevant number of
non‐American Africans are included only in the 1000Genomes collective: 451dupT frequency was 1.29%
in native Africans and 1.56% in African Caribbeans. Conclusions This study underlines the higher preva-
lence of PK deficiency among people with African descent compared to Europeans. In order to avoid
delay of necessary surgical procedures in patients of African origin, diagnostic algorithms for isolated,
unexplained, activated partial thromboplastin time prolongation in these subjects should include PK
deficiency screening.
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Abstract
Background: Severe prekallikrein deficiency (PK deficiency) is an autosomal-reces-
sive condition thought to be very rare. Recently we reported that the previously un-
noticed variant c.451dupT, p.Ser151Phefs*34 in KLKB1, which is listed in databases 
aggregating genome data, causes PK deficiency and is common in Africans according 
to gnomAD (allele frequency 1.43%).
Patients/Methods: The most common African (c.451dupT) and European (c.1643G>A, 
p.Cys548Tyr) PK deficiency causing KLKB1 variants were analyzed in two population-
based collectives of 300 Nigerian and 300 German subjects. Genome databases were 
evaluated for variant frequencies and ethnicity of the subjects. The geographic origin 
of PK-deficient cases due to 451dupT was assessed.
Results: Two of five patients with PK deficiency caused by homozygous 451dupT 
were African, one African American, one from Oman, and one of unknown origin. The 
frequency of 451dupT was 1.17% in the Nigerian collective (7/600 alleles); none had 
Cys548Tyr. Subjects with 451dupT were found among different Nigerian ethnicities. 
Both variants were absent in the European collective. Database research was com-
patible with these findings, even though mainly data of African Americans (451dupT: 
1.12%-1.78%) was accessible. A relevant number of non-American Africans are in-
cluded only in the 1000Genomes collective: 451dupT frequency was 1.29% in native 
Africans and 1.56% in African Caribbeans.
Conclusions: This study underlines the higher prevalence of PK deficiency among 
people with African descent compared to Europeans. In order to avoid delay of nec-
essary surgical procedures in patients of African origin, diagnostic algorithms for 
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1  | INTRODUC TION
Isolated prolongation of the activated partial thromboplastin time 
(aPTT) is a common finding.1 Adequate and timely differential diag-
nostic work-up needs to exclude the presence of a bleeding disorder, 
especially if an invasive procedure is planned. The presence of spe-
cific symptoms may orient the diagnostic workup, which includes the 
identification of pre-analytical issues, the search of coagulation factor 
deficiencies or coagulation factor inhibitors, and detection of lupus an-
ticoagulant. The local availability of rapid diagnostic assays depends on 
the severity of the condition being suspected, its expected prevalence, 
and whether the test is expensive or technically demanding. Severe 
plasma prekallikrein (PK) and high molecular weight kininogen (HK) 
deficiency, two autosomal recessive defects of the contact pathway 
without bleeding diathesis, are considered rare conditions. Therefore, 
no specific assays are established in many diagnostic laboratories.
We recently performed a large, comprehensive study of all cases 
of severe PK deficiency discovered thus far, including an appraisal of 
mutations in the KLKB1 gene and a bioinformatics analysis to estimate 
its prevalence.2 The results suggested very low prevalence of PK de-
ficiency in European collectives, ie, ~1/240 000.2,3 The internationally 
so far unnoticed KLKB1 variant c.451dupT, p.Ser151Phefs*34, which 
is listed in databases aggregating genome data and had been associ-
ated with PK deficiency only in two German-language publications,4,5 
exhibited a much higher frequency in the African (allele frequency 
according to gnomAD 1.43%) compared to the European collective 
(0.03%).2,3 Based on functional and genetic analyses of two native 
African index cases from our center, we were able to show that ho-
mozygosity for 451dupT causes PK deficiency and is associated with 
non-measurable PK antigen. These data suggest a much higher preva-
lence of severe PK deficiency in Africans (~1/4725).2
Confirming this information may have clinical consequences 
for the diagnostic workup of patients of African descent with 
an isolated prolongation of aPTT, allowing a prompt diagnosis of 
largely asymptomatic PK deficiency. In this study, we analyzed the 
frequency of 451dupT and Cys548Tyr in KLKB1 in an African and 
a European population-based collective to support prevalence 
estimates of this condition in relation to ethnic and geographic 
background and to the information available in additional relevant 
variant databases.
2  | METHODS
Previously, we showed that 451dupT may represent the main causal 
variant in subjects of African descent (frequency 1.43%), whereas 
Cys548Tyr is the main variant in Europeans and Latinos (both 0.1%).2 
All other PK deficiency–causing variants were very rare (≤0.03%) 
and described in one to a maximum of three index patients.2 In addi-
tion to the patients described in Barco et al,2 a further patient with 
PK deficiency originating from Oman, whose case had already been 
published (case 6 from Nazir and Pathare6), was genotyped in our 
laboratory (University Medical Center of the Johannes Gutenberg 
University Mainz) for KLKB1 variants.
Detailed protocols and primer sequences for Sanger sequenc-
ing of KLKB1, and pyrosequencing of Cys548Tyr are given in Barco 
et al.2 The same pyrosequencing procedure was applied for 451dupT 
using specific primers (forward: AAGGTGCACCAGTAACATTCG, re-
verse: Bio-CCTTGAATTGTACTCACCGGTACT; sequencing primer: 
CATTCGCTGCCAGTTTTTTT) and an adequate annealing tempera-
ture (56°C).
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isolated, unexplained, activated partial thromboplastin time prolongation in these 
subjects should include PK deficiency screening.
K E Y W O R D S
blood coagulation factors, blood coagulation tests, epidemiology, prekallikrein deficiency, 
prevalence
Essentials
• Prekallikrein (PK) deficiency is a recessive trait with iso-
lated aPTT prolongation.
• KLKB1 c.451dupT is common in Nigerians (7/600 alleles) 
and absent in a European group (0/600).
• To date, all genotyped PK-deficient patients of African 
ancestry were homozygous for 451dupT.
• Diagnostics of isolated aPTT prolongation in African de-
scendants should include PK testing.
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To substantiate the hypothesis of a higher PK deficiency prev-
alence in people of African descent than in Caucasians gained 
from these individual case observations, 300 healthy Nigerian 
and 300 healthy German subjects were analyzed for the two most 
common PK deficiency–causing variants in KLKB1: c.451dupT, 
p.Ser151Phefs*34 (rs560588447) and c.1643G>A, p.Cys548Tyr 
(rs121964951). EDTA blood samples of Nigerian subjects were col-
lected at the Department of Medical Laboratory Sciences, College 
of Medicine, University of Nigeria in Enugu for a population-based 
study (Enugu State Ministry of Health [MH/MSD/EC/0194; 
01.2019-03.2020]). EDTA blood of German subjects (299 of 
European, 1 of Asian descent) was obtained between April and July 
2019 from consecutive participants of the Gutenberg Health Study, 
a population-based, prospective, single-center cohort study enroll-
ing participants from the German Rhine-Main area.7 The studies 
were designed and executed in accordance with all local legal and 
regulatory requirements, notably the Declaration of Helsinki, 7th 
revision.
We accessed the following genetic databases for KLKB1 vari-
ants: (i) dbSNP (build 154), ClinVar, OMIM, Nucleotide, Protein, 
etc: National Center for Biotechnology Information (NCBI) data-
bases, https://www.ncbi.nlm.nih.gov/; (ii) gnomAD3: http://gnomad.
broad insti tute.org/; (iii) NCBI ALFA (Allele Frequency Aggregator) 
project8: https://www.ncbi.nlm.nih.gov/snp/docs/gsr/alfa/; (iv) 
National Heart, Lung, and Blood Institute (NHLBI) GO Exome 
Sequencing Project (ESP)9: https://esp.gs.washi ngton.edu/drupa l/; 
(v) 1000Genomes project, phase 310: https://www.ncbi.nlm.nih.gov/
varia tion/tools/ 1000g enome s/.
The lower and upper limits of the 95% confidence interval 
(95%CI) for population-based allele frequencies was calculated ac-
cording to Wilson et al11 using the web tool http://vassa rstats.net/
prop1.html.
3  | RESULTS AND DISCUSSION
We started the current project based on the fact that no German 
patient with PK deficiency has been diagnosed at the University 
Medical Center Mainz during the past 5 years, but two African-born 
patients were observed, and although they have a different ethnic 
background, both were homozygous for 451dupT.2 One of the re-
cently published PK deficiency cases from Oman6 has now been an-
alyzed for KLKB1 variants at our center in Mainz. A homozygosity for 
451dupT was detected. Together with a recently published report12 
about a case homozygous for 451dupT, and two cases, which had 
already been part of a case summary in Barco et al,2 a total of six PK 
deficiency cases carrying 451dupT are known to date, five of them 
being homozygous and one compound heterozygous (Table 1). Two 
homozygous patients originated from Africa (Ghana and Somalia; 
Figure 1 and Table 1). One homozygous patient is African American 
(personal communication with Thiagarajan P.12; Table 1). The ethnic-
ity of a further homozygous2,4 and a compound heterozygous case2,5 
is unknown.
The mutation Cys548Tyr was described in 11 of 28 genotyped 
index patients, of whom 5 were homozygotes and 6 compound het-
erozygotes.2 The majority of these patients with known ethnicity 
were European (5 Europeans, 1 of Afro-Caribbean origin, 5 of un-
known origin).
Pyrosequencing of 300 Nigerian individuals revealed seven het-
erozygotes for 451dupT (Figure 1) corresponding to an allele fre-
quency of 1.17%. Cys548Tyr was not detected. Subjects with one 
451dupT allele were found among different Nigerian ethnicities: four 
Ibo/Igbo, one Idoma, one Ibibio, and one Urhobo. Figure 1 describes 
the geographic and ethnic distribution of 451dupT in Nigeria and, 
based on this and prior reports,2,6 in the African and Middle-East 
region.
TA B L E  1   All published cases and one newly identified subject with PK deficiency, that is caused by either homozygous or compound 
heterozygous 451dupT variant are listed in the table. The region of origin of the three PK-deficient patients with ethnic information (Oman, 
Ghana, and Somalia) are highlighted in blue for easy comparison with Figure 1
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Note: °= personal communication with Thiagarajan P.12;
Abbreviations; NA, not available; PK, prekallikrein; PK:Ag, prekallikrein antigen; PK:C, prekallikrein clotting activity.
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451dupT and Cys548Tyr were both absent from the European 
collective of 300, mainly German subjects, a finding consistent with 
the rarity of PK deficiency in Europe. The reason more Europeans 
than Africans have been identified with PK deficiency in the past 
is presumably due to the frequency of aPTT testing and the higher 
availability of detailed investigations to study prolonged aPTT in 
Europe.
A more detailed analysis of selected databases revealed that 
451dupT is not only frequent among Africans, but also among indi-
viduals of African descent, including African Americans and African 
Caribbeans:
1. The database of the NCBI ALFA project8 lists 676 African 
alleles, 662 of which are African American. In this relatively 
small sample 451dupT (rs560588447) is found with an allele 
frequency of 0.60% in African Americans. In a total of 8134 
genotyped European alleles the allele frequency of 451dupT 
is given with 0.04%. For Cys548Tyr (rs121964951) NCBI ALFA 
reports a minor allele frequency of 0.086% in Europeans (79 462 
alleles). The variant is absent in Africans (844 African alleles, 
including 828 African-American alleles).8 Interestingly, the clinical 
significance of 451dupT is categorized as “benign” in the NCBI 
databases (dbSNP, ClinVar), while the clinical significance of 
Cys548Tyr is categorized as “uncertain significance” or “patho-
genic.” Nevertheless, it is obvious that both variants are definitely 
causing PK deficiency, whereby homozygosity for 451dupT is 
associated with CRIM (cross reacting immunological material) 
negativity, while homozygosity or compound heterozygosity for 
Cys548Tyr is associated with very low PK activity, but some 
10% of PK antigen (CRIM+).2,13 The latter is consistent with 
the observation of Saito et al,14 who described a CRIM– status 
for 13 African Americans and a CRIM+ status for 5 Caucasian 
individuals, though no genetic data was presented.
2. The GO Exome Sequencing Project of the NHLBI9 presents the 
largest genotyped collective of individuals of African descent. A 
frequency of 1.52% is reported for 451dupT in African Americans 
(4266 alleles) and a frequency of 0.024% in European Americans 
(8254 alleles). Cys548Tyr, on the other hand, is found with a fre-
quency of 0.047% in European Americans (8594 alleles) and is ab-
sent in the African-American collective (4402 alleles).
3. The 1000Genomes project, phase 3,10 presents an interesting 
African collective (consisting of 1322 alleles), which includes 
African Americans (122 alleles), African Caribbeans (192 alleles), 
and, in contrast to the other analyzed databases, a significant num-
ber of genuine African alleles (1008). The frequency of 451dupT 
was 1.36% in the entire African collective, with a frequency of 
F I G U R E  1   Schematic representation of Africa and the Arabian Peninsula to illustrate the broad distribution of KLKB1 c.451dupT in this 
region. Settlement areas of different ethnic groups from Nigeria, analyzed in this report, are shown in purple. Cohorts of the 1000Genomes 
project, which are described in more detail in the text, are marked in dark green. The allele frequencies in percent of 451dupT are given 
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1.64% in African Americans, 1.56% in African Caribbeans, and 
1.29% in native Africans. The detailed frequency distribution 
in the African sub-collectives from Gambia (226 alleles), Sierra 
Leone (170), Nigeria (ethnicities: Yoruba, 216 alleles and Esan, 198 
alleles]), and Kenya (Luhya, 198 alleles) is given in Figure 1. These 
data, as well as our Nigerian collective (ethnicity mainly Igbo), 
confirm the broad distribution of 451dupT in African collectives, 
although 451dupT was not found in Gambia among 226 alleles. 
Cys548Tyr was absent from the African and the European (1006 
alleles) collective in 1000Genomes.
Although our data, as well as database research, suggest that 
451dupT is widely distributed among Africans and individuals of 
African descent (Figure 1, Table 1), further studies are needed to 
expand the dataset and identify regional differences in more detail.
Whether the frequency of 451dupT in African collectives is 
caused by a heterozygote advantage currently remains speculative. 
Several components of the kinin system, including kallikrein, play 
a major role in a series of infectious conditions, such as malaria.15 
Infectious diseases, especially if they are life threatening, can exert a 
strong selection pressure on a population and might cause an advan-
tage for 451dupT heterozygotes.
In summary, according to the collectives studied to date, the fre-
quency of 451dupT, a PK deficiency–causing KLKB1 variant, is 1.24% 
(95%CI: 0.78%-1.95%) in native Africans and not significantly differ-
ent in populations of African descent, including African Americans 
and African Caribbeans (Table 2). This indicates that PK deficiency, 
which is rare in individuals of European origin (PK deficiency–caus-
ing variant Cys548Tyr: 0.1%; the four next most common variants 
0.01%-0.03%, additionally several private variants; estimated preva-
lence of PK deficiency ~ 1:240 0002), is much more frequent in most 
African communities. As no further PK deficiency–causing variants 
have been identified in Africans to date, a rough estimation of PK 
deficiency prevalence from the allele frequency of 451dupT (1.17%, 
95%CI: see Table 2) is possible. Our results suggest a PK deficiency 
prevalence of about 1:7000 for Nigeria. Assuming a population of 
about 206 million, we expect almost 30 000 individuals with PK 
deficiency in Nigeria. So, in a Nigerian laboratory of the size of our 
laboratory in Mainz with about 600 aPTT measurements per day, 
one aPTT prolongation due to PK deficiency can be expected every 
12 days.
Of note, approximately 13% of the U.S. population is of 
African descent,16 200 million in the Americas,17 and 15 million 
in the European Union,18 making this a relevant issue not only 
in Africa, which currently has a population of about 1.3 billion 
people.19 Based on these figures, and the allele frequencies for 
c.451dupT given in Table 2, one could conservatively estimate 
that 200 000 people worldwide might have severe PK deficiency.
Nevertheless, due to the supposed rarity of PK deficiency, the 
vast majority of laboratories do not perform an assay for PK activ-
ity. In order to avoid unnecessary delay of surgical procedures in 
Africans or people of African descent with prolonged aPTT, we rec-
ommend to establish (a) a functional assay to assess PK activity, (b) 
an assay documenting the normalization of aPTT following increased 
pre-incubation time,20 or (c) a simple single nucleotide polymorphism 
assay to confirm the presence of 451dupT.
We would nevertheless like to emphasize that testing for clini-
cally relevant causes of prolonged aPTT has priority. If PK- and HK-
deficient plasmas are available, a laboratory capable of measuring 
other coagulation factors based on a modified aPTT test should also 
be able to measure PK and HK activity in time, because the tech-
niques are the same.
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